MedAdvisor Limited (AU:MDR) has released an update.
MedAdvisor Limited has reported a robust financial performance with a 32% increase in its 4Q FY24 revenue and an impressive 24.6% rise in annual revenue, reaching a record $122 million. The company has seen significant growth in both the US and ANZ markets, and for the first time, has achieved profitability in EBITDA and NPAT. Key to this success has been the expansion of patient engagement programs and strategic initiatives such as the Transformation 360 investment.
For further insights into AU:MDR stock, check out TipRanks’ Stock Analysis page.